Role of neuropeptide y Y 1 and Y 2 receptors on behavioral despair in a rat model of depression with co-morbid anxiety

Neuropharmacology

Volumn 62, Issue 1, 2012, Pages 200-208

  Morales Medina, Julio César ^a,b   Dumont, Yvan ^a   Benoit, Charles Etienne ^a   Bastianetto, Stéphane ^a   Flores, Gonzalo ^c   Fournier, Alain ^d   Quirion, Rémi ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^c BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^d INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Autoradiography; Forced swim test; NPY receptor subtypes; Olfactory bulbectomy; Open field; Social interaction test

Indexed keywords

N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; PEPTIDE YY [3-36];

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; BINDING AFFINITY; BINDING SITE; BRAIN REGION; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; HIPPOCAMPUS; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR BINDING; SOCIAL INTERACTION;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; ARGININE; AUTORADIOGRAPHY; BENZAZEPINES; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; INTERPERSONAL RELATIONS; MALE; NEUROPEPTIDE Y; OLFACTORY BULB; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; SWIMMING; TIME FACTORS;

EID: 80054106936     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.06.030     Document Type: Conference Paper

References (74)

1. S.H. Adams, C. Lei, C.M. Jodka, S.E. Nikoulina, J.A. Hoyt, B. Gedulin, C.M. Mack, and E.S. Kendall PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice J. Nutr. 136 2006 195 201 (Pubitemid 43156508)
2. F. Bacchi, A.A. Mathe, P. Jimenez, L. Stasi, R. Arban, P. Gerrard, and L. Caberlotto Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze Peptides 27 2006 3202 3207 (Pubitemid 44738169)
3. L. Caberlotto, and Y.L. Hurd Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior Neuropsychopharmacology 25 2001 91 97 (Pubitemid 32493825)
4. C. Carvajal, Y. Dumont, H. Herzog, and R. Quirion Emotional behavior in aged neuropeptide Y (NPY) Y2 knockout mice J. Mol. Neurosci. 28 2006 239 245 (Pubitemid 43780316)
5. J.C. Chavez, and J.C. LaManna Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1 J. Neurosci. 22 2002 8922 8931 (Pubitemid 35379062)
6. J.F. Cryan, M.E. Page, and I. Lucki Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment Psychopharmacology (Berl.) 182 2005 335 344 (Pubitemid 41464645)
7. J.F. Cryan, and D.A. Slattery Animal models of mood disorders: recent developments Curr. Opin. Psychiatry 20 2007 1 7 (Pubitemid 44901068)
8. Y. Dumont, J.G. Chabot, and R. Quirion Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides Peptides 25 2004 365 391 (Pubitemid 38591550)
9. Y. Dumont, A. Fournier, and R. Quirion Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain J. Neurosci. 18 1998 5565 5574 (Pubitemid 28341337)
10. Y. Dumont, D. Jacques, P. Bouchard, and R. Quirion Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains J. Comp. Neurol. 402 1998 372 384 (Pubitemid 28541685)
11. Y. Dumont, A. Fournier, S. St-Pierre, and R. Quirion Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31, Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands J. Pharmacol. Exp. Ther. 272 1995 673 680
12. Y. Dumont, D. Jacques, J. St-Pierre, Y. Tong, R. Parker, H. Herzog, and R. Quirion Neuropeptide Y, peptide YY and pancreatic polypeptide receptor proteins and mRNAs in mammalian brain R. Quirion, A. Bjorklund, T. Hokfelt, Peptide Receptors, Part 1 first ed. 2000 Elsevier Science B.V. Amsterdam 375 475
13. Y. Dumont, J.C. Morales-Medina, and R. Quirion Neuropeptide Y an its role in anxiety-related disorders S. Shioda, I. Homma, N. Kato, Transmitters and Modulators in Health and Disease 2009 Springer Kato Bunmeisha 51 82
14. Y. Dumont, E. Moyse, A. Fournier, and R. Quirion Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain J. Pharmacol. Exp. Ther. 315 2005 99 108 (Pubitemid 41380502)
15. Y. Dumont, and R. Quirion [(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors Br. J. Pharmacol. 129 2000 37 46 (Pubitemid 30072669)
16. Y. Dumont, and R. Quirion An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization G. Feuernstein, Z. Zukowska-Grojec, Progress in Inflammation Research 2006 Birkhauser Varlag Basel 7 33
17. S.E. File The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs J. Neurosci. Methods 2 1980 219 238 (Pubitemid 10050361)
18. S.E. File, and P. Seth A review of 25 years of the social interaction test Eur. J. Pharmacol. 463 2003 35 53 (Pubitemid 36205071)
19. M. Forest, J.C. Martel, S. St-Pierre, R. Quirion, and A. Fournier Structural study of the N-terminal segment of neuropeptide tyrosine J. Med. Chem. 33 1990 1615 1619 (Pubitemid 20180619)
20. S.N. Goyal, M.A. Upadhya, D.M. Kokare, S.M. Bhisikar, and N.K. Subhedar Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors Brain Res. 1266 2009 45 53
21. A. Gregus, A.J. Wintink, A.C. Davis, and L.E. Kalynchuk Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats Behav. Brain Res. 156 2005 105 114 (Pubitemid 39330441)
22. S. Hasegawa, A. Watanabe, K.Q. Nguyen, G. Debonnel, and M. Diksic Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study Psychopharmacology (Berl.) 179 2005 781 790 (Pubitemid 40767898)
23. M. Heilig, B. Soderpalm, J.A. Engel, and E. Widerlov Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models Psychopharmacology (Berl.) 98 1989 524 529 (Pubitemid 19193902)
24. M. Heilig, O. Zachrisson, A. Thorsell, A. Ehnvall, S. Mottagui-Tabar, M. Sjogren, M. Asberg, R. Ekman, C. Wahlestedt, and H. Agren Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism J. Psychiatr. Res. 38 2004 113 121 (Pubitemid 38134451)
25. P.A. Hipskind, K.L. Lobb, J.A. Nixon, T.C. Britton, R.F. Bruns, J. Catlow, D.K. Dieckman-McGinty, S.L. Gackenheimer, B.D. Gitter, S. Iyengar, D.A. Schober, R.M. Simmons, S. Swanson, H. Zarrinmayeh, D.M. Zimmerman, and D.R. Gehlert Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists J. Med. Chem. 40 1997 3712 3714 (Pubitemid 127744506)
26. P.V. Holmes Rodent models of depression: reexamining validity without anthropomorphic inference Crit. Rev. Neurobiol. 15 2003 143 174 (Pubitemid 38160442)
27. P.V. Holmes, R.C. Davis, C.V. Masini, and S.D. Primeaux Effects of olfactory bulbectomy on neuropeptide gene expression in the rat olfactory/limbic system Neuroscience 86 1998 587 596 (Pubitemid 28293935)
28. C. Hou, F. Jia, Y. Liu, and L. Li CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder Brain Res. 1095 2006 154 158 (Pubitemid 43866025)
29. A.V. Kalueff, and P. Tuohimaa Contrasting grooming phenotypes in C57Bl/6 and 129S1/SvImJ mice Brain Res. 1028 2004 75 82 (Pubitemid 39424181)
30. L.E. Kalynchuk, A. Gregus, D. Boudreau, and T.S. Perrot-Sinal Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats Behav. Neurosci. 118 2004 1365 1377 (Pubitemid 39578483)
31. S. Kantor, Z.E. Anheuer, and G. Bagdy High social anxiety and low aggression in Fawn-Hooded rats Physiol. Behav. 71 2000 551 557 (Pubitemid 32184780)
32. A. Kask, J. Harro, S. von Horsten, J.P. Redrobe, Y. Dumont, and R. Quirion The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y Neurosci. Biobehav. Rev. 26 2002 259 283 (Pubitemid 34555409)
33. A. Kask, E. Vasar, L.T. Heidmets, L. Allikmets, and J.E. Wikberg Neuropeptide Y Y(5) receptor antagonist CGP71683A: the effects on food intake and anxiety-related behavior in the rat Eur. J. Pharmacol. 414 2001 215 224 (Pubitemid 32181889)
34. J.P. Kelly, A.S. Wrynn, and B.E. Leonard The olfactory bulbectomized rat as a model of depression: an update Pharmacol. Ther. 74 1997 299 316 (Pubitemid 27425352)
35. P.J. King, P.S. Widdowson, H.N. Doods, and G. Williams Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices J. Neurochem 73 1999 641 646 (Pubitemid 29339837)
36. P.J. King, G. Williams, H. Doods, and P.S. Widdowson Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release Eur. J. Pharmacol 396 2000 R1 R3
37. Y. Liu, and Z.X. Wang Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles Neuroscience 121 2003 537 544 (Pubitemid 38367494)
38. I. Lucki The forced swimming test as a model for core and component behavioral effects of antidepressant drugs Behav. Pharmacol. 8 1997 523 532 (Pubitemid 27504702)
39. M.C. Michel, A. Beck-Sickinger, H. Cox, H.N. Doods, H. Herzog, D. Larhammar, R. Quirion, T. Schwartz, and T. Westfall XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors Pharmacol. Rev. 50 1998 143 150 (Pubitemid 28158845)
40. R. Mitra, and R.M. Sapolsky Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy Proc. Natl. Acad. Sci. U.S.A. 105 2008 5573 5578 (Pubitemid 351753904)
41. Morales-Medina, J., Juarez, I., Venancio-García, E., Cabrera, S., Flores, G., Menard, C., Quirion, R., 2010a. Major morphological reorganization of key brain regions in the olfactory bulbectomized rat Canadian neuroscience meeting.
42. J.C. Morales-Medina, Y. Dumont, and R. Quirion A possible role of neuropeptide Y in depression and stress Brain Res. 1314 2010 194 205
43. J.C. Morales-Medina, and R. Quirion Role of neuropeptide Y in depression: current status F. Lopez Munoz, C. Alamo, Neurobiology of Depression 2011 CRC Press
44. R. Moriya, S. Mashiko, A. Ishihara, T. Takahashi, T. Murai, J. Ito, Y. Mitobe, Z. Oda, H. Iwaasa, F. Takehiro, and A. Kanatani Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice Peptides 30 2009 1318 1322
45. I.D. Neumann, G. Wegener, J.R. Homberg, H. Cohen, D.A. Slattery, J. Zohar, J.D. Olivier, and A.A. Mathe Animal models of depression and anxiety: what do they tell us about human condition? Prog. Neuropsychopharmacol. Biol. Psychiatry 2010
46. E. Painsipp, H. Herzog, and P. Holzer Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice Neuropharmacology 55 2008 117 126
47. E. Painsipp, T. Wultsch, M.E. Edelsbrunner, R.O. Tasan, N. Singewald, H. Herzog, and P. Holzer Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice Genes Brain Behav. 7 2008 532 542 (Pubitemid 351991488)
48. Pandey, D.K., Mahesh, R., Kumar, A.A., Rao, V.S., Arjun, M., Rajkumar, R. A novel 5-HT(2A) receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants. Pharmacol. Biochem. Behav. 94:363-373.
49. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1986 Academic Press North Ryde
50. R.D. Porsolt, M. Le Pichon, and M. Jalfre Depression: a new animal model sensitive to antidepressant treatments Nature 266 1977 730 732 (Pubitemid 8073804)
51. S.D. Primeaux, and P.V. Holmes Olfactory bulbectomy increases met-enkephalin- and neuropeptide-Y-like immunoreactivity in rat limbic structures Pharm. Biochem. Behav. 67 2000 331 337 (Pubitemid 32000839)
52. R. Rajkumar, D.K. Pandey, R. Mahesh, and R. Radha 1-(m-Chlorophenyl) piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay Eur. J. Pharmacol. 608 2009 32 41
53. J.P. Redrobe, Y. Dumont, A. Fournier, and R. Quirion The Neuropeptide Y (NPY) Y1 Receptor Subtype Mediates NPY-induced antidepressant-like activity in the mouse forced swimming test Neuropsychopharmacology 26 2002 615 624 (Pubitemid 34260980)
54. J.P. Redrobe, Y. Dumont, H. Herzog, and R. Quirion Characterization of Neuropeptide Y, Y2 receptor knockout mice in two animal models of learning and memory processing J. Mol. Neurosci. 22 2003 121 128
55. J.P. Redrobe, Y. Dumont, H. Herzog, and R. Quirion Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice Behav. Brain Res. 141 2003 251 255 (Pubitemid 36542973)
56. S. Rotzinger, D.A. Lovejoy, and L.A. Tan Behavioral effects of neuropeptides in rodent models of depression and anxiety Peptides 31 2009 736 756
57. N.J. Rutkoski, A.A. Lerant, C.M. Nolte, J. Westberry, and C.W. Levenson Regulation of neuropeptide Y in the rat amygdala following unilateral olfactory bulbectomy Brain Res. 951 2002 69 76 (Pubitemid 35253898)
58. T.J. Sajdyk, D.A. Schober, D.L. Smiley, and D.R. Gehlert Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala Pharmacol. Biochem. Behav. 71 2002 419 423 (Pubitemid 34117711)
59. T.J. Sajdyk, M.G. Vandergriff, and D.R. Gehlert Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test Eur. J. Pharmacol. 368 1999 143 147 (Pubitemid 29117135)
60. C. Song, B. Earley, and B.E. Leonard The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression Brain Behav. Immun. 10 1996 1 16 (Pubitemid 26168466)
61. C. Song, and B.E. Leonard The olfactory bulbectomised rat as a model of depression Neurosci. Biobehav. Rev. 29 2005 627 647 (Pubitemid 40755458)
62. G. Sorensen, C. Lindberg, G. Wortwein, T.G. Bolwig, and D.P. Woldbye Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation J. Neurosci. Res. 77 2004 723 729 (Pubitemid 39194614)
63. K.A. Stogner, and P.V. Holmes Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats Eur. J. Pharmacol. 387 2000 R9 10
64. S. Tanaka, L.W. Fan, L.T. Tien, Y. Park, L.Y. Liu-Chen, R.W. Rockhold, and I.K. Ho Butorphanol dependence increases hippocampal kappa-opioid receptor gene expression J. Neurosci. Res. 82 2005 255 263 (Pubitemid 41648764)
65. R.O. Tasan, S. Lin, A. Hetzenauer, N. Singewald, H. Herzog, and G. Sperk Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice Neuroscience 158 2009 1717 1730
66. K. Tatemoto, M. Carlquist, and V. Mutt Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide Nature 296 1982 659 660 (Pubitemid 12089070)
67. S. Thakker-Varia, and J. Alder Neuropeptides in depression: role of VGF Behav. Brain Res. 197 2009 262 278
68. C.T. To, Z.E. Anheuer, and G. Bagdy Effects of acute and chronic fluoxetine treatment of CRH-induced anxiety Neuroreport 10 1999 553 555 (Pubitemid 29333281)
69. A. Tschenett, N. Singewald, M. Carli, C. Balducci, P. Salchner, A. Vezzani, H. Herzog, and G. Sperk Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors Eur. J. Neurosci 18 2003 143 148 (Pubitemid 36920855)
70. M.W. Walker, T.D. Wolinsky, V. Jubian, G. Chandrasena, H. Zhong, X. Huang, S. Miller, L.G. Hegde, D.A. Marsteller, M.R. Marzabadi, M. Papp, D.H. Overstreet, C.P. Gerald, and D.A. Craig The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol- 2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity J. Pharmacol. Exp. Ther. 328 2009 900 911
71. D. Wang, Y. Noda, H. Tsunekawa, Y. Zhou, M. Miyazaki, K. Senzaki, and T. Nabeshima Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety Behav. Brain Res. 178 2007 262 273 (Pubitemid 46341443)
72. A. Watanabe, Y. Tohyama, K.Q. Nguyen, S. Hasegawa, G. Debonnel, and M. Diksic Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: an autoradiographic study J. Neurochem. 85 2003 469 475 (Pubitemid 36438342)
73. E. Widerlov, L.H. Lindstrom, C. Wahlestedt, and R. Ekman Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively J. Psychiatr. Res. 22 1988 69 79
74. J. Zhang, M.K. Matheny, N. Tumer, M.K. Mitchell, and P.J. Scarpace Leptin antagonist reveals that the normalization of caloric intake and the thermic effect of food after high-fat feeding are leptin dependent Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 2007 R868 R874